Native Meta creative and exact outbound link observed October 22, 2026. Redirects were followed to the captured public destination. Actual GLP-1 acquisition creative; peptide/sermorelin keyword searches showed no matches. Advertiser claims are source material; activity does not establish performance. No personal, health or payment details were entered.

A long care page develops a direct offer through product quality, treatment comparisons, care steps, customer stories and assessment entry. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
It's about as simple as a price ad gets: one number, a product label, two terms and the vial. The huge $129/mo is readable at any size, the green background matches the vial cap so the whole card feels like the product, and the commitment terms answer the biggest worry about subscriptions. As a billboard-style static it gives the account a fast, readable format to rotate in next to the busier comparison charts. Eden ran several versions of this creative from September 4, 2026.
There's no problem in it and the price doesn't match the copy. The card says $129 while the ad headline and copy say $99, which is confusing for a price-only ad. And without a problem line, the viewer has to already be shopping for GLP-1 to care; anyone earlier in the decision just sees a number. Match the headline to the card, and add a short line above the price that names what the viewer is escaping (prices that rise with the dose, annual prepay).
The product color and background match, so the card reads as the product itself.
One big number is readable at feed size, and the terms answer the subscription worry right away.
It adds the care promise, though its price differs from the card's.
$129 a month for compounded tirzepatide on the card, with no annual commitment; the headline and copy say $99 a dose.
The click goes to Eden's GLP-1 affiliate page, a focused landing page that shows $129/mo tirzepatide in the hero right beside $99/mo semaglutide, so the card's number is there the moment the page loads. The Start my free assessment button and the takes-3-minutes line give a clear next step, and the plan inclusions section further down explains what the price covers. For a price billboard, it's a close match.
Eden's GLP-1 affiliate page is a long, focused landing page that opens on semaglutide at $99/mo and tirzepatide at $129/mo with a free assessment, then covers quality, treatment, care steps, stories and FAQs. All 16 Eden ads in the Fluid library link here, mostly price comparisons plus creator and doctor videos.
The headline, three benefits, both monthly prices and the free assessment button answer what it costs and how to start, with Trustpilot and member-count proof alongside.
It covers where the medication comes from and who oversees care, answering whether a low price means cutting corners.
It explains the problem and how the treatment is meant to work, answering why someone would consider it at all.
It compares treatment options so the visitor can work out which one fits before starting the assessment.
It walks through the steps from assessment to ongoing care, answering what happens after the click.
It shows stories from customers, answering whether people like the visitor have used the service.
It lists what the plan includes and repeats the assessment entry, answering what the monthly price covers right before asking again.
It handles remaining questions and the safety and compounding disclosures, answering the last objections before signing up.
Read the full breakdown of this page
One of 16 Eden ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.